Oxaliplatin
Title: Oxaliplatin
CAS Registry Number: 61825-94-3
CAS Name: (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-kN,kN¢][ethanedioato(2-)-kO1,kO2]platinum
Additional Names: [(1R,2R)-1,2-cyclohexanediamine-N,N¢][oxalato (2-)-O,O¢]platinum; oxalato (1R,2R-cyclohexanediamine)platinum(II); Pt(oxalato)(trans-l-dach); oxalato (trans-l-1,2-diaminocyclohexane)platinum (II); oxalatoplatin; oxalatoplatinum; l-OHP
Manufacturers' Codes: RP-54780; NSC-266046
Trademarks: Eloxatin (Sanofi-Aventis); Elplat (Debiopharm)
Molecular Formula: C8H14N2O4Pt
Molecular Weight: 397.29
Percent Composition: C 24.19%, H 3.55%, N 7.05%, O 16.11%, Pt 49.10%
Literature References: Third generation platinum complex. Prepn and antitumor activity: Y. Kidani et al., J. Med. Chem. 21, 1315 (1978); Y. Kidani et al., Gann 71, 637 (1980). Crystal structure: M. A. Bruck et al., Inorg. Chim. Acta 92, 279 (1984). FAB and LAMMA MS analysis: J. Claereboudt et al., J. Pharm. Biomed. Anal. 7, 1599 (1989). Pharmacokinetics: R. Kizu et al., Cancer Chemother. Pharmacol. 31, 475 (1993). Clinical evaluation in colorectal cancer: F. Levi et al., Eur. J. Cancer 29A, 1280 (1993). Brief review of antitumor and clinical activity: G. Mathé et al., Biomed. Pharmacother. 43, 237-250 (1989). Review of clinical experience in combination therapy for colorectal cancer: D. Simpson et al., Drugs 63, 2127-2156 (2003).
Properties: Colorless, thin triangular plates with truncated vertices. Sol in water 7.9 mg/ml.
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Platinum Complexes.

Others monographs:
BuprenorphineAllopregnane1-Chloro-2-buteneC-Curarine III
SepimostatIsomaltolDoxepinAcesulfame
Manganese Phosphate, DibasicQuillaja SaponinPhenyl SalicylatePotassium Perchlorate
Ammonium Chromate(VI)Starch, SolubleCalcium Phosphate, DibasicPhenyramidol
©2016 DrugLead US FDA&EMEA